current pipeline

The projects we currently have in our pipeline

NCT: Over-the-Counter

A rare natural product that activates the cell’s master metabolic control switch - finally available at scale. NCT opens a new category in metabolic wellness by addressing cellular energy efficiency rather than symptoms.

NCT: Pharma

A first-in-class approach to treating multiple metabolic diseases through a single upstream mechanism. Platform-enabled analogs of NCT unlock a previously inaccessible pharmaceutical pathway with clear acquisition relevance.

Non-intoxicating Cannabinoids

Novel, non-intoxicating molecules inspired by cannabinoid biology but unconstrained by traditional chemistry. The platform enables rapid exploration of new chemical space with multiple therapeutic and commercial pathways.

Santalene

A high-value fragrance molecule constrained by scarcity and unsustainable extraction. Cell-free production transforms santalene into a predictable, scalable ingredient while opening access to adjacent aromatic compounds.

Leading the biomanufacturing revolution

eXoZymes is redefining how complex molecules are discovered, manufactured, and commercialized. Its AI-enhanced, cell-free biomanufacturing platform turns rare, unscalable, or economically inaccessible chemistry into predictable, high-purity production. By embedding manufacturability directly into discovery, eXoZymes collapses development timelines, lowers capital intensity, and unlocks multiple commercialization paths. The result is a scalable platform with durable IP, capital-light growth, and asymmetric upside across pharmaceutical, wellness, and industrial markets.

enzymes x AI = exozymes
Exozymes are advanced enzymes enhanced through AI and bioengineering to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient biochemical extraction with sustainable and scalable biosolutions that transform biomass into medicines and nutraceuticals. By freeing enzyme-driven chemical reactions from the limitations imposed by cells, exozyme biosolutions eliminate the scaling bottleneck that has hampered commercial success in the synthetic biology (SynBio) space, making exozymes the next generation of biomanufacturing.

Evolution in nature is one mutation per generation over thousands of years - we do that in a week